PPARG and Peritoneal Fibrosis: In terms of PD-induced peritoneal fibrosis, previous reports using both animal and cellular models demonstrated the effective suppression of PD/high glucose-induced PF development by treatments with PPARγ agonists such as Telmisartan and pioglitazone [16, 17].